Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekaterini Kotsopoulou

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Methods & Clinical Development|March 15, 2021
Enriching leukapheresis improves T cell activation and transduction efficiency during CAR T processingElsa Noaks, Carlotta Peticone, Ekaterini Kotsopoulou, et al.
Oncoimmunology|January 25, 2021
Single-cell transcriptome analysis of CAR T-cell products reveals subpopulations, stimulation, and exhaustion signaturesXiaonan Wang, Carlotta Peticone, Ekaterini Kotsopoulou, et al.
Journal of Biotechnology|February 17, 2010
Optimised mammalian expression through the coupling of codon adaptation with gene amplification: maximum yields with minimum effortEkaterini Kotsopoulou, Hella Bosteels, Yuen-Ting Chim, et al.
Experimental Hematology|March 10, 2012
Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineagesDominik Spensberger, Ekaterini Kotsopoulou, Rita Ferreira, et al.
European Journal of Immunology|August 30, 2012
Increased red cell turnover in a line of CD22-deficient mice is caused by Gpi1c: a model for hereditary haemolytic anaemiaJennifer A Walker, Andrew M Hall, Ekaterini Kotsopoulou, et al.
Molecular Therapy. Methods & Clinical Development|December 15, 2018
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging CellLeila Mekkaoui, Farhaan Parekh, Ekaterini Kotsopoulou, et al.
Molecular and Cellular Biology|February 18, 2004
The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1Berthold Göttgens, Cyril Broccardo, Maria-Jose Sanchez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|March 15, 2021
Enriching leukapheresis improves T cell activation and transduction efficiency during CAR T processingElsa Noaks, Carlotta Peticone, Ekaterini Kotsopoulou, et al.
Oncoimmunology|January 25, 2021
Single-cell transcriptome analysis of CAR T-cell products reveals subpopulations, stimulation, and exhaustion signaturesXiaonan Wang, Carlotta Peticone, Ekaterini Kotsopoulou, et al.
Journal of Biotechnology|February 17, 2010
Optimised mammalian expression through the coupling of codon adaptation with gene amplification: maximum yields with minimum effortEkaterini Kotsopoulou, Hella Bosteels, Yuen-Ting Chim, et al.
Experimental Hematology|March 10, 2012
Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineagesDominik Spensberger, Ekaterini Kotsopoulou, Rita Ferreira, et al.
European Journal of Immunology|August 30, 2012
Increased red cell turnover in a line of CD22-deficient mice is caused by Gpi1c: a model for hereditary haemolytic anaemiaJennifer A Walker, Andrew M Hall, Ekaterini Kotsopoulou, et al.
Molecular Therapy. Methods & Clinical Development|December 15, 2018
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging CellLeila Mekkaoui, Farhaan Parekh, Ekaterini Kotsopoulou, et al.
Molecular and Cellular Biology|February 18, 2004
The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1Berthold Göttgens, Cyril Broccardo, Maria-Jose Sanchez, et al.
Pageof 1